Ticker
EYPTCompany Name
EYEPOINT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 1.91M | 3.68% | $ 51.9M |
3/31/2025 | $ 1.73M | 3.09% | $ 56.04M |
12/31/2024 | $ 1.54M | 3.56% | $ 43.27M |
9/30/2024 | $ 1.19M | 2.59% | $ 45.71M |
6/30/2024 | $ 892K | 1.77% | $ 50.39M |
3/31/2024 | $ 662K | 1.32% | $ 50.02M |
12/31/2023 | $ 464K | 1.01% | $ 46.02M |
9/30/2023 | $ 687K | 1.62% | $ 42.52M |
6/30/2023 | $ 1.28M | 3.44% | $ 37.33M |
3/31/2023 | $ 1.85M | 4.66% | $ 39.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor / Revenues
(=) DepAmor %
DepAmor % for EYEPOINT PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 2.63M ] / Revenues [ $ 35.94M ]
(=) DepAmor % [ 7.32% ]
Minimum
Dec 31, 2023
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.32K |
---|---|
min | -6.41% |
max | 22.52% |
average | 5.85% |
median | 4.2% |
std | 5.13% |